<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP16793347A1" file="16793347.2" lang="en" country="EP" doc-number="3294273" kind="A1" date-publ="20180321" status="n" dtd-version="ep-patent-document-v1-5"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMA....MD..........</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>BDM Ver 0.1.63 (23 May 2017) -  1100000/0</B007EP></eptags></B000><B100><B110>3294273</B110><B130>A1</B130><B140><date>20180321</date></B140><B190>EP</B190></B100><B200><B210>16793347.2</B210><B220><date>20160509</date></B220><B240><B241><date>20171027</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201562159134 P</B310><B320><date>20150508</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20180321</date><bnum>201812</bnum></B405><B430><date>20180321</date><bnum>201812</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K   9/48        20060101AFI20161122BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  39/395       20060101ALI20161122BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61M  31/00        20060101ALI20161122BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C07K  16/24        20060101ALI20161122BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>ANTI-INTERLEUKIN-ANTIKÖRPERZUBEREITUNGEN ZUR FREISETZUNG IN EIN LUMEN DES DARMTRAKTES MIT EINER EINNEHMBAREN WIRKSTOFFFREISETZUNGSVORRICHTUNG</B542><B541>en</B541><B542>ANTI-INTERLEUKIN ANTIBODY PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE</B542><B541>fr</B541><B542>PRÉPARATIONS D'ANTICORPS ANTI-INTERLEUKINES À ADMINISTRER DANS LA LUMIÈRE DU TRACTUS INTESTINAL AU MOYEN D'UN DISPOSITIF D'ADMINISTRATION PHARMACOLOGIQUE À AVALER</B542></B540></B500><B700><B710><B711><snm>Incube Labs, LLC</snm><iid>101557057</iid><irf>KER/P548233EPPC</irf><adr><str>2501 Ringwood Avenue</str><city>San Jose, CA 95131</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>IMRAN, Mir</snm><adr><str>12894 Brendel Drive</str><city>Los Altos Hills, CA 94022</city><ctry>US</ctry></adr></B721><B721><snm>KORUPOLU, Radhika</snm><adr><str>2051 Ringwood Avenue</str><city>San Jose, CA 95131</city><ctry>US</ctry></adr></B721><B721><snm>To, Elaine</snm><adr><str>2051 Ringwood Avenue</str><city>San Jose, CA 95131</city><ctry>US</ctry></adr></B721><B721><snm>HASHIM, Mir</snm><adr><str>45179 Ram Court</str><city>Fremont, CA 94539</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Rees, Kerry</snm><iid>101382422</iid><adr><str>WP Thompson 
138 Fetter Lane</str><city>London EC4A 1BT</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>BA</ctry></B845EP><B845EP><ctry>ME</ctry></B845EP></B844EP><B848EP><B849EP><ctry>MA</ctry></B849EP><B849EP><ctry>MD</ctry></B849EP></B848EP><B860><B861><dnum><anum>US2016031548</anum></dnum><date>20160509</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2016183040</pnum></dnum><date>20161117</date><bnum>201646</bnum></B871></B870></B800></SDOBI></ep-patent-document>